FDA DrugClass IINotable

FDA Recall: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella

Date: 2026-05-13

Brand: Acella Pharmaceuticals, LLC

Category: Drug

FDA Class: Class II

Description

Chemical contamination; presence of lead and lithium above specification

Hazard

Chemical contamination; presence of lead and lithium above specification

Remedy

6,336 bottles

View original recall →

Share:

Related Recalls

2026-06-24 · FDA_DRUG

FDA Recall: Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz (30 mL), Manufactured for

Keystone Industries

2026-06-24 · FDA_DRUG

FDA Recall: Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ (30 g), Distributed by

Keystone Industries

2026-06-24 · FDA_DRUG

FDA Recall: Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewat

Ajanta Pharma USA Inc

2026-06-24 · FDA_DRUG

FDA Recall: PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), Strawberry Flavor, Manufactured for

Keystone Industries